Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2000
09/21/2000WO2000054773A1 Dopamine agonists in combination with nitric oxide donors, compositions and methods of use
09/21/2000WO2000054772A1 Amyotropic lateral sclerosis treatment with a combination of riluzole and an ampa receptor antagonist
09/21/2000WO2000054771A1 The use of 3,5-pyrazolidinedione derivatives to combat viral infections
09/21/2000WO2000054769A1 Protease inhibitors
09/21/2000WO2000054768A1 Anti-first-pass effect compounds
09/21/2000WO2000054767A1 Use of lipoxin compounds for inhibiting of tnf-(alfa) initiated neutrophil response
09/21/2000WO2000054766A1 Agents and methods for promoting production gains in animals
09/21/2000WO2000054765A1 Method of treating eating disorders
09/21/2000WO2000054764A2 A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
09/21/2000WO2000054763A2 Pharmaceutical compositions comprising polymorphic forms of dehydroepiandrosterone
09/21/2000WO2000054762A2 Use of cross linked polysaccharides for the inhibition of angiogenesis
09/21/2000WO2000054761A2 Regulation of phospholipase d activity
09/21/2000WO2000054760A2 Bicyclo (3.3.1) nonenes useful for the treatment of diabetes and hypertriglyceridemia
09/21/2000WO2000054759A2 Lxr modulators
09/21/2000WO2000054758A2 Method for delivering benzidine prostaglandins by inhalation
09/21/2000WO2000054757A2 Use of pirenoxine for the protection of corneal tissues in photokeratectomy
09/21/2000WO2000054756A2 Nitrate esters and their use for introducing neuroprotection and cognition enhancement
09/21/2000WO2000054754A2 Composition comprising isoquercetin and ascorbic acid in a sustained release form
09/21/2000WO2000054751A1 Method for producing solid dosage forms containing cyclodextrin
09/21/2000WO2000054750A1 Method for correcting disturbance in collagen synthesis and biologically active substance for realising the same
09/21/2000WO2000054748A1 Metered dose inhalers with isobutane as propellant
09/21/2000WO2000054747A2 Method for treating dry eye
09/21/2000WO2000054745A2 Devices and methods for pain management
09/21/2000WO2000054743A1 Cosmetic and/or pharmaceutical preparations
09/21/2000WO2000054729A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2000WO2000054610A1 Food complement and method for cosmetic treatment based on a grape extract rich in polyphenols
09/21/2000WO2000054588A1 Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages
09/21/2000WO2000054587A1 Antimicrobial skin preparations containing organosilane quaternaries
09/21/2000WO2000040583A3 Imidazo[4,5-c]-pyridine-4-on-derivatives
09/21/2000WO2000040225A3 Inhibition of tnf activity
09/21/2000WO2000039077A3 Thyroid receptor ligands
09/21/2000WO2000038785A3 Methods for treating certain diseases using naaladase inhibitors
09/21/2000WO2000032577A3 Substituted benzo[de]isoquinoline-1,3-diones
09/21/2000WO2000027868A3 Connective tissue growth factor (ctgf) and methods of use
09/21/2000WO2000027828A3 2,4-disubstituted triazine derivatives with anti hiv activity
09/21/2000WO2000026227A9 Ldl related protein and uses thereof
09/21/2000WO2000026185A9 Omeprazole solution and method of using same
09/21/2000WO2000025819A9 Enhanced radiation therapy
09/21/2000WO2000025800A9 Steroid receptor rna activator
09/21/2000WO2000025766A3 Use of nk antagonist for treating gastric asthma
09/21/2000WO2000021550A8 Methods and compositions for treating neurodegenerative diseases
09/21/2000WO2000020039A9 Methods and adjuvants for stimulating mucosal immunity
09/21/2000WO2000019992A9 Method for treating insulin resistance through hepatic nitric oxide
09/21/2000WO2000018407A9 Methods for preventing/treating damage to sensory hair cells and cochlear neurons
09/21/2000WO2000013662A3 Medicated chewing gum delivery system for nicotine
09/21/2000WO2000012508A3 Pyrrolbenzodiazepines
09/21/2000WO2000010551A3 Methods of using and compositions comprising dopamine reuptake inhibitors
09/21/2000WO2000006136A3 Therapeutic combination of polyamine with an anticancer agent
09/21/2000WO2000004865A3 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
09/21/2000WO2000002551A3 Methods and compounds for treating depression
09/21/2000WO2000001668A3 Naaladase inhibitors useful as pharmaceutical compounds and compositions
09/21/2000WO2000000192A9 INHIBITION OF NF-λB MEDIATED TISSUE INJURY USING DITHIOCARBAMATE DERIVATIVES
09/21/2000WO1999039706A9 Pharmaceuticals comprising n,n'-bis(2- hydroxybenzyl) ethylenediamine-n, n'-diacetic acid for iron chelating therapy
09/21/2000DE19918105C1 Transdermal patch for administering neuroleptic agent i.e. fluphenazine, flupentixol or triflupromazine, includes matrix layer containing penetration enhancer and hydrocarbon polymer
09/21/2000DE19912638A1 Naphthylcarbonsäureamid-substituierte Sulfonamide Naphthylcarbonsäureamid-substituted sulfonamides
09/21/2000DE19912636A1 Bicyclische Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und pharmazeutische Mittel Bicyclic heterocycles, process for their preparation and their use as herbicides and pharmaceutical compositions
09/21/2000DE19912573A1 Arzneimittel, enthaltend Doxazosin-Mesylat der Kristallmodifikaton D A drug containing doxazosin mesylate of Kristallmodifikaton D
09/21/2000DE19912436A1 Ibuprofen-Lösung Ibuprofen solution
09/21/2000DE19912063A1 Neues Verfahren zur Herstellung von Doxazosin-Mesylat in einer als Form A bezeichneten Kristallmodifikation New process for the preparation of doxazosin mesylate in a crystal modification, referred to as Form A
09/21/2000DE19911510A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation
09/21/2000DE19911509A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation
09/21/2000DE19911371A1 Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen Drugs for the treatment of functional disorders and diseases of the lower intestinal tracts, especially of associated abdominal visceral pain
09/21/2000DE19911329A1 Humantherapeutisch anwendbares Radioimmunkonjugat und Verfahren zu seiner Herstellung Human Therapeutic applicable radioimmunoconjugate and process for its preparation
09/21/2000DE19911053A1 Kosmetische und/oder pharmazeutische Zubereitungen Cosmetic and / or pharmaceutical preparations
09/21/2000DE19910682A1 Fibrate based preparation for treating hyperlipoproteinemia additionally contains vitamin or related compound, e.g. cobalamin or folic acid, to prevent the side effect of hyperhomocysteinemia
09/21/2000DE19901502C1 Anticellulitiszusammensetzung und ihre Verwendung Anticellulitiszusammensetzung and their use
09/21/2000CA2768688A1 Regulation of phospholipase d activity
09/21/2000CA2747376A1 Use of lipoxin compounds for inhibiting of tnf-(alpha) initiated neutrophil response
09/21/2000CA2675416A1 Lipoxin compounds and their use
09/21/2000CA2475069A1 Amine derivatives as protease inhibitors
09/21/2000CA2369319A1 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
09/21/2000CA2368242A1 Combination therapy for treating glaucoma
09/21/2000CA2368150A1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors
09/21/2000CA2368148A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368122A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368068A1 27 human secreted proteins
09/21/2000CA2367906A1 Tcl-1b gene and protein and related methods and compositions
09/21/2000CA2367895A1 Compounds and methods for modulation of estrogen receptors
09/21/2000CA2367643A1 Ocular therapy in keratoconjuctivitis sicca using topically applied androgens or tgf-.beta.
09/21/2000CA2367605A1 Apomorphine and sildenafil composition
09/21/2000CA2367595A1 Lxr modulators
09/21/2000CA2367461A1 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2000CA2367447A1 Treatment of asthma
09/21/2000CA2367444A1 Agents and methods for promoting production gains in animals
09/21/2000CA2367409A1 Metering valve
09/21/2000CA2367354A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents
09/21/2000CA2367352A1 Amine derivatives as protease inhibitors
09/21/2000CA2367340A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000CA2367256A1 Surface localized colligin/hsp47 in carcinoma cells
09/21/2000CA2367213A1 Novel antiangiogenic peptides
09/21/2000CA2366838A1 A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
09/21/2000CA2366195A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000CA2366174A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000CA2366130A1 Human cancer associated gene sequences and polypeptides
09/21/2000CA2365767A1 Angiogenesis inhibition
09/21/2000CA2365096A1 Polyunsaturated fatty acid (pufa) elongase from caenorhabditis elegans
09/21/2000CA2364637A1 50 human secreted proteins
09/21/2000CA2364629A1 Human lung cancer associated gene sequences and polypeptides
09/21/2000CA2364590A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000CA2364549A1 50 human secreted proteins
1 ... 6242 6243 6244 6245 6246 6247 6248 6249 6250 6251 6252 6253 6254 6255 6256 6257 6258 6259 6260 6261 6262 ... 7860